Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence.

@article{Lee2010PostoperativeCO,
  title={Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence.},
  author={Dong Yun Lee and D. H. Bae and B K Yoon and DooSeok Choi},
  journal={Human reproduction},
  year={2010},
  volume={25 12},
  pages={3050-4}
}
BACKGROUND Currently, no standard post-operative medical therapy has been shown to be superior in reducing the recurrence of endometrioma. This retrospective study was performed to evaluate the efficacy of post-operative cyclic oral contraceptive (OC) use after GnRH agonist (GnRHa) treatment for the prevention of endometrioma recurrence. METHODS This retrospective study included 362 reproductive-aged patients who had undergone pelviscopic surgery for endometrioma. Patients were divided into… CONTINUE READING